Misophonia Research Impact Award Grant

REAM FOUNDATION

Funding Amount

Up to US $500,000

Deadline

Rolling / Open

Grant Type

foundation

Overview

Misophonia Research Impact Award Grant

Status: ACTIVE
Funder: Ream Foundation
Amount: Up to US $500,000
Last Updated: January 22, 2026

Summary

The Misophonia Research Fund is inviting applications for research projects aimed at understanding misophonia, its symptoms, and potential treatments. Up to 10 grants of $500,000 will support independent researchers at qualifying institutions. Postdoctoral researchers may also apply for grants of $200,000. The fund emphasizes the need for innovative approaches in characterizing misophonia, developing objective assessment methods, and evaluating interventions, ensuring a comprehensive exploration of this complex disorder.

Overview

Misophonia Research Fund Description Postdoctoral applicants are also encouraged to apply to the Misophonia Research Fund. Postdoctoral researchers are eligible for a grant that will provide up to US$200,000 in total funding support for their research projects. Each postdoctoral grant may span two to three years, depending on the proposed project’s needs, but the total funding amount will remain up to $200,000 in either scenario. These grants are intended to support postdoctoral researchers who will have earned their doctoral degree (e.g., Ph.D., M.D., Psy.D., Au.D.) by July 1, 2025, and are under the mentorship of a doctoral-level principal investigator at a qualifying research-based institution. Scientific Focus: The scientific focus of proposals shall address one or more of the following three broad focus areas in human, animal, or relevant research models. Proposals can focus on a specific area or may address multiple of the following areas: Characterization of misophonia. Proposals may include a wide range of approaches to examine including:testable theories, basic animal models, and human translational models addressing why, how, and for whom misophonia develops;underlying biological, behavioral, and/or environmental mechanisms (and their interactions) underlying the etiology, longitudinal development, maintenance, and/or treatment of misophonia;expression and trajectory of symptoms, impairment, and related phenomena, including individual variability and trends within and between populations;the use of multiple measurement methods (e.g., questionnaires, behavioral and physiological measurements) and the development of diagnostic criteria according to these measurements;the epidemiology and prevalence of misophonia, as this may inform the scope and significance of misophonia as a public health problem;individual differences in demographic factors, especially with underrepresented and marginalized populations;characterization of non-Western and/or non-US/UK/Canadian populations to understand the role of culture in misophonia; andthe influence of contextual factors on the development and expression of misophonia (e.g., family, friends, school, community). Development of objective methods. Proposals may develop or validate physiological and/or behavioral methods (i.e., objective assessments) to assess misophonia.Clinical and/or animal model studies. Proposals should use rigorous experimental methods to develop and/or evaluate the acceptability, feasibility, and efficacy of interventions for misophonia. Clinically-oriented proposals may collect pilot data to inform future, larger randomized controlled trials but must still include rigorously constructed control and experimental groups

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Focus Areas & Funding Uses

Fields of Work

science-research

Categories

Browse similar grants by category

Related Grants

Similar grants from this funder and related organizations

Ready to apply for Misophonia Research Impact Award Grant?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.